Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Full-length next-generation sequencing of HLA class I and II genes in a cohort from Thailand.

Geretz A, Ehrenberg PK, Bouckenooghe A, Fernández Viña MA, Michael NL, Chansinghakule D, Limkittikul K, Thomas R.

Hum Immunol. 2018 Nov;79(11):773-780. doi: 10.1016/j.humimm.2018.09.005. Epub 2018 Sep 19.

PMID:
30243890
2.

High-Throughput Contiguous Full-Length Next-Generation Sequencing of HLA Class I and II Genes from 96 Donors in a Single MiSeq Run.

Ehrenberg PK, Geretz A, Thomas R.

Methods Mol Biol. 2018;1802:89-100. doi: 10.1007/978-1-4939-8546-3_6.

PMID:
29858803
3.

High-throughput next-generation sequencing to genotype six classical HLA loci from 96 donors in a single MiSeq run.

Ehrenberg PK, Geretz A, Sindhu RK, Vayntrub T, Fernández Viña MA, Apps R, Michael NL, Thomas R.

HLA. 2017 Nov;90(5):284-291. doi: 10.1111/tan.13133. Epub 2017 Sep 14.

PMID:
28842944
4.

Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region.

Jobe O, Trinh HV, Kim J, Alsalmi W, Tovanabutra S, Ehrenberg PK, Peachman KK, Gao G, Thomas R, Kim JH, Michael NL, Alving CR, Rao VB, Rao M.

J Leukoc Biol. 2016 Jun;99(6):1089-106. doi: 10.1189/jlb.2A0815-361R. Epub 2015 Dec 14.

5.

HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition.

Prentice HA, Tomaras GD, Geraghty DE, Apps R, Fong Y, Ehrenberg PK, Rolland M, Kijak GH, Krebs SJ, Nelson W, DeCamp A, Shen X, Yates NL, Zolla-Pazner S, Nitayaphan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Ferrari G, McElrath MJ, Montefiori DC, Bailer RT, Koup RA, O'Connell RJ, Robb ML, Michael NL, Gilbert PB, Kim JH, Thomas R.

Sci Transl Med. 2015 Jul 15;7(296):296ra112. doi: 10.1126/scitranslmed.aab4005.

6.

HLA class II diversity in HIV-1 uninfected individuals from the placebo arm of the RV144 Thai vaccine efficacy trial.

Baldwin KM, Ehrenberg PK, Geretz A, Prentice HA, Nitayaphan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, O'Connell RJ, Kim JH, Thomas R.

Tissue Antigens. 2015 Feb;85(2):117-26. doi: 10.1111/tan.12507.

7.

High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging.

Ehrenberg PK, Geretz A, Baldwin KM, Apps R, Polonis VR, Robb ML, Kim JH, Michael NL, Thomas R.

BMC Genomics. 2014 Oct 6;15:864. doi: 10.1186/1471-2164-15-864.

8.

HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial.

Prentice HA, Ehrenberg PK, Baldwin KM, Geretz A, Andrews C, Nitayaphan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, O'Connell RJ, Robb ML, Kim JH, Michael NL, Thomas R.

Immunogenetics. 2014 May;66(5):299-310. doi: 10.1007/s00251-014-0765-6. Epub 2014 Mar 29.

PMID:
24682434
9.
10.

Demonstration of de novo HIV type 1 production by detection of multiply spliced and unspliced HIV type 1 RNA in paraffin-embedded tonsils.

Brachtel EF, Mascola JR, Wear DJ, Ehrenberg PK, Dayhoff DE, Sanders-Buell E, Michael NL, Frankel SS.

AIDS Res Hum Retroviruses. 2002 Jul 20;18(11):785-90.

PMID:
12167270
11.
12.

Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction.

Salminen MO, Ehrenberg PK, Mascola JR, Dayhoff DE, Merling R, Blake B, Louder M, Hegerich S, Polonis VR, Birx DL, Robb ML, McCutchan FE, Michael NL.

Virology. 2000 Dec 5;278(1):103-10.

13.

Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells.

Frankel SS, Steinman RM, Michael NL, Kim SR, Bhardwaj N, Pope M, Louder MK, Ehrenberg PK, Parren PW, Burton DR, Katinger H, VanCott TC, Robb ML, Birx DL, Mascola JR.

J Virol. 1998 Dec;72(12):9788-94.

14.

Genomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1.

Wegner SA, Ehrenberg PK, Chang G, Dayhoff DE, Sleeker AL, Michael NL.

J Biol Chem. 1998 Feb 20;273(8):4754-60.

15.

Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction.

Salminen MO, Koch C, Sanders-Buell E, Ehrenberg PK, Michael NL, Carr JK, Burke DS, McCutchan FE.

Virology. 1995 Oct 20;213(1):80-6.

16.

Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus.

Michael NL, Chang G, d'Arcy LA, Ehrenberg PK, Mariani R, Busch MP, Birx DL, Schwartz DH.

J Virol. 1995 Jul;69(7):4228-36.

18.

Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat.

Michael NL, Vahey MT, d'Arcy L, Ehrenberg PK, Mosca JD, Rappaport J, Redfield RR.

J Virol. 1994 Feb;68(2):979-87.

19.

HIV-1 proviral genotypes from the peripheral blood mononuclear cells of an infected patient are differentially represented in expressed sequences.

Michael NL, Chang G, Ehrenberg PK, Vahey MT, Redfield RR.

J Acquir Immune Defic Syndr. 1993 Oct;6(10):1073-85.

PMID:
8105071

Supplemental Content

Loading ...
Support Center